| Common Brands | Breztri Aerosphere |
|---|---|
|
Drug Class |
ICS / LAMA / LABA |
|
Controlled Substance Classification |
Not a controlled medication |
|
Generic Status |
No Lower-cost generic available |
|
Availability |
Prescription only |
Breoztri Aerosphere is an inhaled prescription medication that should be used for the chronic obstructive pulmonary disease treatment, which includes the prevention of symptoms like shortness of breath, wheezing, and coughing. Breoztri Aerosphere includes a single inhaler with two active ingredients-budesonide and formoterol fumarate. It is designed to improve airflow, reduce inflammation in the airways, and enhance the overall management of COPD in patients who need a combination of a corticosteroid and a long-acting beta-agonist (LABA).
Breztri Aerosphere is a maintenance treatment and is not meant to provide immediate relief for acute COPD symptoms or exacerbations. It usually prescribed in the long run, mainly to decrease flare-ups of varying severity, which ultimately enhances the quality of life in patients diagnosed with moderate to severe COPD.
Breztri Aerosphere is available in a pressurized metered-dose inhaler (pMDI) that is easy to use. The inhaler delivers a precise dose of the medication directly into the lungs. Here’s how to use Breztri Aerosphere correctly:
Shake the Inhaler:
Before using, shake the inhaler well to ensure the medication is well mixed. Prime the Inhaler (if necessary):
If you are using Breztri Aerosphere for the first time or if it has not been used for more than 7 days, you will need to prime the inhaler. Spray it into the air so as to release a dose of the medication before use.
Breathe Out Completely:
Slowly breathe out, away from the inhaler, so that your lungs completely empty.
Inhale Medication:
Insert the mouthpiece in your mouth with your lips tightly closed over it. Inhale very forcefully and deeply into your mouth. While inhaling, activate the inhaler by depressing the canister.
Hold Breath
Continue to hold the breath in your lungs for at least 10 seconds (as comfortable).
Slowly Breathe Out
Let your breath out slowly and easily. Repeat if Necessary
If your doctor has prescribed more than one inhalation, wait about 30 seconds before using the inhaler again and repeat the steps as needed.
Breztri Aerosphere acts through the combined action of its two active ingredients:
Budesonide (Corticosteroid):
Budesonide reduces inflammation of the lungs by suppressing activation of inflammatory cells and chemicals such as leukotrienes and cytokines. These reduce airway swelling and improve airflow, prevent the narrowing of airways due to inflammation, and help prevent the production of mucous characteristic of COPD.
Formoterol fumarate (LABA):
Formoterol is a long-acting beta-agonist (LABA) which activates beta-2 adrenergic receptors on the smooth muscle of the airways. It leads to relaxation of the muscles so that the airways expand and remain open for an extended period of time and provide long-lasting relief from breathing difficulties.
Together, these two drugs synergistically reduce inflammation and relax the airway muscles, thus improving the airflow and making it easier to breathe. This combination, over time, helps in controlling the symptoms of COPD and prevents exacerbation.
Like all medications, Breztri Aerosphere can have side effects. Common side effects that are experienced with the use of Breztri Aerosphere include:
Irreversible throat irritation
Some patients experience a sore throat or hoarseness associated with using the inhaler.
A cough can occur with some mild cough especially after use of the inhaler when medication is irritating the back of the throat.
Inhalation of medications produces headaches, a common result.
Upper Respiratory Tract Infections: In some patients, Breztri Aerosphere may lead to an increased risk for respiratory infections, such as sore throat or sinus infections.
Oral Candidiasis (Thrush): The corticosteroid of Breztri Aerosphere, budesonide, increases the risk for developing fungal infections in the mouth – oral thrush. Rinsing the mouth after dosing helps to minimize this risk.
Not for Acute Symptoms: Breztri Aerosphere is a maintenance medication and should not be used for the relief of sudden breathing problems. Patients should use a rescue inhaler (e.g., albuterol) for immediate relief during an acute COPD flare-up.
Long-term treatment with inhaled corticosteroids such as budesonide can increase the chance of pneumonia. Symptoms of pneumonia include fever, chills, cough, and labored breathing.
Cardiovascular Disease: Formoterol being a beta-agonist can cause a change in heart rhythm and blood pressure. So, patients suffering from cardiovascular diseases, hypertension, or arrhythmias must take Breztri Aerosphere under careful consideration.
Possible Long-Term Side Effects of Corticosteroid Therapeutic Agents: Long-term effects of corticosteroid drugs like budesonide include bone thinning and cataracts, due to adrenal suppression.
Children and Adolescents: There is no approval for administration in children under 18 years of age.
Always discuss with your healthcare provider before combining Breztri Aerosphere with other medications to ensure safety and effectiveness.
The recommended dose for Breztri Aerosphere in patients with COPD is:
1 inhalation once daily, which delivers 160 mcg budesonide and 4.8 mcg formoterol per inhalation.
Patients should follow the recommended dosage and should never take more than the required amount for the day. Patients who missed a dose of this drug should take it immediately if they remember; however, patients should not take two doses together because they missed one.
Breztri Aerosphere is a prescription-only medication. A healthcare provider’s prescription is needed for this medication. A patient should have regular checks of their symptoms and lung function by a doctor in order to determine the treatment course of their condition.
Breztri Aerosphere is a prescription inhalation aerosol that combines two active ingredients, budesonide (a corticosteroid) and formoterol fumarate (a long-acting beta-agonist), used for the management of asthma and COPD.
Breztri Aerosphere works by reducing inflammation in the airways and relaxing the muscles around the airways, which helps to improve breathing and control symptoms of asthma and COPD.
Breztri Aerosphere is prescribed for adults and children aged 12 years and older with asthma or for adults with COPD who require a maintenance treatment for their condition.
Breztri Aerosphere is delivered via an aerosol inhaler. Patients inhale a specific dose directly from the inhaler, usually twice daily—once in the morning and once in the evening.
The recommended dosage is one inhalation twice daily. The healthcare provider will determine the appropriate dosage based on the patient’s condition and response to treatment.
Common side effects may include headache, throat irritation, coughing, and nausea. Some patients may also experience a sore throat or an increase in respiratory tract infections.
Yes, serious side effects can include increased heart rate, worsening of asthma symptoms, severe allergic reactions, and potential adrenal insufficiency. Seek immediate medical attention if you have these symptoms.
No, Breztri Aerosphere is not intended for acute relief of asthma or COPD symptoms. It is a maintenance medication, and patients should use a separate rescue inhaler for sudden breathing difficulties.
Patients may start to feel relief from symptoms within the first few hours after using Breztri Aerosphere, but it may take one to two weeks for the full benefits to be realized.
Pregnant or breastfeeding women should consult their healthcare provider before using Breztri Aerosphere, as the risks and benefits need to be weighed carefully.
Yes, Breztri Aerosphere may interact with certain medications, including other bronchodilators, corticosteroids, and some antidepressants. It’s essential to inform your healthcare provider about all medications you are taking.
Store Breztri Aerosphere at room temperature, away from moisture and heat. Keep it out of reach of children and do not use it after the expiration date on the label.
If you miss a dose, take it as soon as you remember. If it is almost time for your next dose, skip the missed dose and resume your regular dosing schedule. Do not double up on doses.
The inhaler should be cleaned at least once a week. Wipe the mouthpiece with a clean, dry cloth to prevent medication buildup.
Patients should monitor for any worsening of symptoms. It’s also important to avoid getting the inhaler in the eyes and to use it only as prescribed by a healthcare provider.
Do not stop taking Breztri Aerosphere suddenly without consulting your healthcare provider, as this may worsen your respiratory condition. Gradual reduction may be necessary for some patients.
Breztri Aerosphere is approved for use in children aged 12 years and older. For younger children, consult a healthcare provider for appropriate alternatives or treatments.
Coverage for Breztri Aerosphere can vary by insurance plan. Patients should check with their insurance provider to determine coverage and any associated costs.
Breztri Aerosphere is typically used as a long-term maintenance treatment. Your healthcare provider will evaluate its continued effectiveness and safety during regularly scheduled appointments.
For more information, speak with your healthcare provider, read the patient information leaflet that comes with the medication, or visit the official website of the manufacturer.
Seborrheic dermatitis is a widespread chronic inflammatory skin disorder that primarily affects the head, scalp, and upper trunk, which are areas rich in sebaceous glands.
For a considerable time, both scientists and medical experts have been fascinated by the connection between the gastrointestinal tract and the brain. The gut-brain axis
Food intolerances are becoming more widely acknowledged as serious health issues impacting people all over the world. In contrast to food allergies, which are immune
